Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02015078 · ClinicalTrials.gov registry record

Black Family Eating Behaviors Study

A clinical trial of Obesity and Cancer, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
314
Enrollment target
1
Study location

NCT02015078: Completed study of Obesity and Cancer, sponsored by National Human Genome Research Institute (NHGRI).

NCT02015078 is a study of Obesity and Cancer that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 314 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02015078, a study of Obesity and Cancer, has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
314 participants
Enrollment target
1
Study location

Study Summary

Despite broad awareness of the role that diet plays in increasing obesity risk, adherence to public health recommendations for maintaining healthy eating is low. Insights gained from weight loss intervention trials find that trial participants report difficulty in restricting calories, dissatisfaction with the pace of weight loss, inability to control eating, low palatability of recommended foods and strong food cravings. Indeed, recent systematic reviews provide empirical support that these subjective experiences that trial participants describe likely represent eating-related traits or phenotypes . While amassing evidence supports individual variation in these eating-related traits, to date there has been no systematic effort to characterize robust eating-related phenotypes. Proposed is a Sub-study initially planned to be piggy-backed on a planned Study being conducted by investigators at the University of North Carolina (UNC-- Linnan, Dilworth- Anderson \& Evans). The UNC Parent Study was a feasibility study using community-based participatory research (CBPR) approaches to explore possible intervention strategies aimed to reduce the burden of chronic disease and cancer among African American families. The NHGRI-led eating behavior Sub-study is proposed to be integrated with the UNC Parent Study (hereafter referred to as Phase 1). The additional aims of the Sub-study (hereafter referred to as Phase 2) are to gain understanding of whether we can characterize clusters of eating-related behaviors that may be associated with adherence to weight management and weight outcomes. This current protocol lays out the specific qualitative activities planned for Phase 1 which include conducting structured interviews with Black Family Reunion organizers (N=8) and a sample of reunion participants (N=40). We also describe the larger quantitative survey proposed for Phase 2. Pending the feasibility of the sub-study with the African-American community, we will collect information o

Primary Outcome

To assess whether the occurrence of robust eating- related behavior clusters differ significantly between blood relatives and non-blood relatives (i.e., spouses and unrelated kin).

Conditions Studied

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 314 participants
Start Date 2013-12-14
Est. Completion 2015-06-22

What the finished NCT02015078 record still lists

NCT02015078 is an observational study that tracks outcomes without assigning an intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (62% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT02015078 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02015078 about?

NCT02015078 is a clinical study titled "Black Family Eating Behaviors Study". Despite broad awareness of the role that diet plays in increasing obesity risk, adherence to public health recommendations for maintaining healthy eating is low. Insights gained from weight loss intervention trials find that trial participants report difficulty in restricting calories, dissatisfacti...

What is the current status of trial NCT02015078?

This trial is currently completed. The enrollment target is 314 participants. The study started on 2013-12-14. Estimated completion is 2015-06-22.

What conditions does trial NCT02015078 study?

This clinical trial studies the following conditions: Obesity, Cancer.

Who is sponsoring clinical trial NCT02015078?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02015078 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02015078's enrollment target sits among peer trials

314 209th of 1053 higher than 845 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03866382 · 314 participants · Phase 2

    Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • NCT04500756 · 314 participants · Phase 2

    Limiting AAA With Metformin (LIMIT) Trial

  • NCT06167746 · 314 participants · Phase 3

    iCare4Me Transitions

  • NCT06883097 · 314 participants · NA

    Quitting Matters Human Immunodeficiency Virus Hybrid Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02015078, the US trial registry maintained by the National Library of Medicine. NCT02015078 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.